New Jersey, United States, - The latest research report added to Intellect Repository of market research is an in-depth analysis of the worldwide Spearmint...
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...